Interventions for Relapsing Depression: TMS, ECT, and Ketamine

Similar documents
Interventions for Relapsing Depression: TMS, ECT, and Ketamine

Neuromodulation Approaches to Treatment Resistant Depression

Statement on Repetitive Transcranial Magnetic Stimulation for Depression. Position statement CERT03/17

rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies

Transcranial Magnetic Stimulation for the Treatment of Depression

Frequently Asked Questions FAQS. NeuroStar TMS Therapies

TMS: Full Board or Expedited?

The New Clinical Science of ECT

Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder

BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?

Objectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS

Repetitive transcranial magnetic stimulation for depression

Some newer, investigational approaches to treating refractory major depression are being used.

What is Repetitive Transcranial Magnetic Stimulation?

Todd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D.

Psychopharmacology 1: ECT

Bright Nights: Understanding Depression

Transcranial Magnetic Stimulation

Treatment of Depression: A Brief History

The Next Chapter in Brain Stimulation Therapy

Case 2:15-cv MWF-JPR Document Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1

Are you not responding to antidepressants?

Clinical Perspective on Conducting TRD Studies. Hans Eriksson, M.D., Ph.D., M.B.A. Chief Medical Specialist, H. Lundbeck A/S Valby, Denmark

American University of Beirut University of Minnesota present. Depression: A complex landscape

ª The Author(s) The Canadian Journal of Psychiatry / La Revue Canadienne de Psychiatrie 1-15

FDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION

Original Effective Date: 8/28/2013. Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression

Transcranial Magnetic Stimulation:

Noninvasive Neuromodulation Current State & Future Directions

Repetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders

Nonpharmacologic Interventions for Treatment-Resistant Depression. Public Meeting December 9, 2011

Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC.

Brain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN

Transcranial Magnetic Stimulation (TMS)

The Evidence Base for rtms Reimbursement

Charles H. Kellner, MD

Mending the Mind: treatment of the severely mentally ill

DEEP TMS TREATMENT CONSENT FORM

Resolved: Targeted Intermittent Device Delivered Interventions will Ultimately Prove Superior to Maintenance Treatment with Drugs for Brain Disorders

Repetitive Transcranial Magnetic Stimulation (rtms)

Transcranial Direct Current Stimulation (tdcs) A Promising Treatment for Depression?

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Transcranial Magnetic Stimulation

Practice Guideline for the Treatment of Patients With Major Depressive Disorder: American Psychiatric Association

The Effect of Cranial Electrotherapy on Preoperative Anxiety and Hemodynamic Responses

Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders Corporate Medical Policy

Understand the New 2019 Neurostimulator Analysis-Programming CPT Coding Structure and Associated Relative Value Units

Therapeutic Neuromodulation: Overview of a Novel Treatment Platform

Treatment-resistant depression in primary care

Aging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health

Biological treatments: Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Light therapy

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Brain Stimulation in Psychiatry

Transcranial Direct-Current Stimulation

Patient Education Brief. NeuroStar TMS Therapies

Laurence M. Hirshberg, Sufen Chiu, and Jean A. Frazier

Clinical Policy Title: Ketamine for treatment-resistant depression

Zinging the Blues. By Kathy Svitil

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

Neuromodulation in Epilepsy. Frederick Langendorf,, MD Department of Neurology Univ of MN and Hennepin Co Medical Center June 4, 2007

Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders

Supplemental Data. Inclusion/exclusion criteria for major depressive disorder group and healthy control group

HCT Medical Policy. Transcranial Magnetic Stimulation (TMS) for Major Depression Policy # 121 Current Effective Date: 05/24/2016.

The Neurobiology of Mood Disorders

Low-Intensity Transcranial Current Stimulation in Psychiatry

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Setting up a TMS Treatment Program

Transcranial magnetic stimulation for the treatment of major depression

EEG Changes (Research Abstracts)

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

Administration of repetitive transcranial magnetic stimulation (rtms)

AP PSYCH Unit 13.3 Biomedical Therapies

Information for patients, families and caregivers

TRANSCRANIAL MAGNETIC STIMULATION

obsessive-compulsive disorder; OCD

Clinical Use of Ketamine in Psychiatry

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Curriculum Vitae, Michael J. Downing, M.D.

Repetitive Transcranial Magnetic Stimulation (rtms) and intravenous ketamine for treatment-resistant depression (TRD)

Index. Note: Page numbers of article titles are in boldface type.

Surgical Treatment for Movement Disorders

IEHP UM Subcommittee Approved Authorization Guidelines Electroconvulsive Therapy- ECT

arxiv: v1 [q-bio.nc] 9 Dec 2011

Disclosures. Objectives. The Neurobiology of Therapeutic Neuromodulation: Implications for Psychiatric Mental Health Nurses

BRAINSWAY DEEP TMS SYSTEM

Interventional Psychiatry

IV Ketamine Infusions for the Treatment of Depression: An Evidence Based Practice Analysis Sergio A. Quinones, SRNA Bryan College of Health Sciences

Neuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.

Correspondence should be addressed to Basant Pradhan;

Implementing treatment. Biomedical Treatments for Major Depressive Disorder

Are they still doing that?

Affective Disorders.

The Context: Why is this so important to treat?

Electroconvulsive therapy and its place in the management of depression Ankush Singhal MD, MRCPsych

EE 4BD4 Lecture 20. Therapeutic Stimulation

SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009

Transcription:

Interventions for Relapsing Depression: TMS, ECT, and Ketamine

MDD top cause of disability; suicide only top-10 cause of death currently increasing. 10-15% lifetime prevalence A third of patients do not respond after multiple rounds of meds. Remission with lithium-augmentation in third round of STAR*D 16% 13.7% of all level 3 patients remitted; a third of those well after 12 months.

Other approaches being investigated: neutraceuticals, probiotics, nicotine, suboxone, psilocybin, hyperthermia, dopamine agonists, ketamine and derivatives Neurostimulation: Invasive devices: VNS,* DBS Non-invasive: tdcs, CES,... ECT** and TMS: routinely covered, evidence for TRD, and regulatory approval

Non-Invasive Brain Stimulation all generate electrical current in the brain. 1. Current vs. magnetic field at site of stimulation? 2. Seizure or not?

e- magnet ECT MST convulsive subconvulsive TES TMS (TDCS, TACS)

TMS Why magnets: Faraday; cortex as conductive material Motor threshold for determining dose Activation of DLPFC and associated networks: monamine turnover, BDNF, HPA axis No cognitive side effects Why subconvulsive: Anesthesia not used. Fewer staff, lower costs, scalable Less stigma, no activity restrictions

Efficacy and Safety 2018 Consensus Recommendations for the Clinical Application of rtms in the Treatment of Depression. APA and NNDC task forces Multiple randomized controlled trials and published literature have supported the safety and efficacy of rtms antidepressant therapy. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rtms). There is a sufficient body of evidence to accept with level A (definite efficacy) the antidepressant effect of HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC).

Discussing Safety with Patients

Patient selection Severe depressive episode, not responding to meds Can attend brief sessions every weekday for 4-6 weeks. Chronic SI and anxiety disorders are common Compatible with ongoing psychotherapy, group therapy, IOP, etc. Not manic or mixed, psychotic, acutely suicidal. If ECT is an antipsychotic, mood stabilizer, antidepressant... then TMS is just an antidepressant.

Cost Trends ECT: performance continues improving with "modern ECT" anesthesia, staff requirements limit potential for cost reduction facility bound (payer rules against even ASC) TMS: v1: high variable costs, 37 min. session v2: generic systems, 17 min. session v3: ultra rapid (theta burst) 3-4 min. session, FDA cleared protocol in 2018

Ketamine Brain Stimulation-Like: High percentage of drug-resistant patients respond Rates between TMS and ECT Dosed intermittently and facility-bound TMS in clinics, ECT in hospitals, Ketamine in clinics with IV, RN Drug-like: Bottom-up MOA: NMDA, AMPA?, opioid systems Durability of benefit in drug-resistant population being studied For severe depression, suicidal ideation, chronic pain; NOT psychotic Sessions twice per week for several weeks. Mildly dissociative or drowsy for up to an 1 hour post infusion. When chronically abused at high doses cognitive or systemic (cystitis) side effects r Dependency/MOA controversy: Naltrexone blocks antidepressant but not dissociative effects Short term opioid effect + NMDA antagonism for longer term benefit

Summary Drug-resistant depression a growing problem The safety and efficacy of TMS and ECT for TRD are well established. For many cases of severe depression, TMS fills a gap between drug resistance and ECT Longer term safety and efficacy of Ketamine being studied and debated

Electroconvulsive Therapy: What s Old is New Mehul Mankad, MD Assistant Professor, Duke University Chief of Psychiatry, Durham VA

In the beginning Ladislas Von Meduna (1930s) Gliosis, Seizures, and Psychiatry Chemical Convulsive Therapy Camphor and pentylenetetrazol

Pushing electrons Ugo Cerletti (late 1930s) Alternating, sinusoidal current Reliably produced GTC sz Bilateral electrode placement Scientific embargo until after WWII

Index Treatment: 6-12 individual sessions, typically MWF The ECT Procedure Now Can be delivered inpt or outpt Requires full general anesthesia (sedation and relaxation) Variation in anesthesia, waveform, and electrode placement

ECT Waveform 1. Pulse width 2. Frequency 3. Peak current 4. Duration

ECT Waveform 1. Pulse width 2. Frequency 3. Peak current 4. Duration

Electrode Placement NEJM

ECT Efficacy Higher acute remission rates than with ANY OTHER treatment (48% for TRD pts) Relapse rates are high if ECT monotherapy is stopped, but can be mitigated with continuation pharmacotherapy (34%) M-ECT is surprisingly equally effective to rx Jelovac et al., 2013

ECT Adverse Effects Cognitive Cardiovascular Neurologic Mankad et al., 2010

ECT Experience Driving = No! Cannot drive to/from ECT Recommended not to drive during index course Working and big decisions are not recommended If outpatient, need a reliable support system Early mornings and possible long wait times

DIY Brain Stimulation CES, TDCS, etc. Wired.com

Cranial Electrotherapy Stimulation (CES) FDA Class III through pre-amendment pathway, requires rx Alternating current, may increase monoamines, may have similar effects in EEG as meditation Fisher Wallace: Scalp electrodes, 2 AA batteries Alpha Stim Ear clips, 2 AAA batteries

CES 26 trial meta-analysis of RCTs. No conclusive evidence for efficacy in fibromyalgia, headache, DJD, depression, or insomnia Cochrane review was negative. Really difficult to do blinded studies Data suggests that CES is very safe but is there an opportunity cost? Shekelle et al., 2018

Transcranial Direct Current Stimulation (TDCS) Polarity matters: Anode = depolarization Cathode = hyperpolarization Hypoactive L DLPFC and hyperactive R DLPFC can be addressed simultaneously Mixed results in treatment of depression or improving cognition 9V battery, available on Amazon

and more Vagus Nerve Stimulation Deep Brain Stimulation Low intensity cranial ultrasound Magnetic seizure therapy

Déjà vu all over again "The employment of electricity in medicine has passed through many vicissitudes, being at one time recognized and employed at the hospitals, and again being neglected, and left for the most part in the hands of ignorant persons, who continue to perpetrate the grossest impositions in the name of electricity. As each fresh important discovery in electric science has been reached, men s minds have been turned anew to the subject, and interest in its therapeutic properties has been stimulated. Then after extravagant hopes and promises of cure, there have followed failures, which have thrown the employment of this agent into disrepute, to be again after time revived and brought into popular favor. H. Lewis Jones, MD, J Mental Science, 1901